American Portfolios Advisors - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$808,622
+3.2%
14,450
-4.5%
0.03%
+6.2%
Q2 2022$783,232
-30.7%
15,132
-2.7%
0.03%
-17.9%
Q1 2022$1,130,091
-45.0%
15,551
-10.5%
0.04%
-43.5%
Q4 2021$2,053,947
-7.0%
17,371
+5.6%
0.07%
-16.9%
Q3 2021$2,207,572
-25.1%
16,456
-9.6%
0.08%
-27.2%
Q2 2021$2,945,791
+30.1%
18,194
-35.5%
0.11%
+15.2%
Q1 2021$2,264,234
+78.6%
28,213
+21.1%
0.10%
+52.3%
Q4 2020$1,267,683
+357.6%
23,303
+67.2%
0.06%
+306.2%
Q3 2020$277,008
+115.0%
13,934
+127.4%
0.02%
+100.0%
Q2 2020$128,811
+652.3%
6,128
+337.7%
0.01%
+700.0%
Q1 2020$17,122
+225.1%
1,400
+290.0%
0.00%
Q4 2019$5,267
+9.9%
3590.0%0.00%
Q3 2019$4,793
-36.2%
359
-21.8%
0.00%
-100.0%
Q2 2019$7,514
-4.2%
4590.0%0.00%0.0%
Q1 2019$7,840
+25.1%
4590.0%0.00%0.0%
Q4 2018$6,265
-62.8%
459
-22.1%
0.00%
-50.0%
Q3 2018$16,857
+4.6%
5890.0%0.00%0.0%
Q2 2018$16,115
+511.3%
589
+371.2%
0.00%
Q1 2018$2,6361250.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders